ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 226 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,479,984 | +100.5% | 3,765,600 | +92.3% | 0.14% | +97.3% |
| Q2 2023 | $24,678,851 | +12843.8% | 1,958,639 | +13306.2% | 0.07% | +7200.0% |
| Q1 2023 | $190,661 | -97.3% | 14,610 | -96.4% | 0.00% | -95.8% |
| Q4 2022 | $7,089,516 | -52.5% | 401,900 | -59.0% | 0.02% | -60.0% |
| Q3 2022 | $14,935,000 | -19.6% | 980,600 | -21.7% | 0.06% | -23.1% |
| Q2 2022 | $18,578,000 | +1308.5% | 1,252,700 | +832.1% | 0.08% | +1014.3% |
| Q4 2019 | $1,319,000 | +265.4% | 134,400 | +308.5% | 0.01% | +250.0% |
| Q3 2019 | $361,000 | -66.4% | 32,900 | -70.8% | 0.00% | -60.0% |
| Q1 2019 | $1,073,000 | -62.4% | 112,495 | -43.8% | 0.01% | -58.3% |
| Q3 2018 | $2,850,000 | -59.9% | 200,000 | -64.1% | 0.01% | -70.0% |
| Q2 2017 | $7,107,000 | +55.1% | 557,000 | +60.1% | 0.04% | +25.0% |
| Q3 2016 | $4,582,000 | -67.5% | 347,900 | -70.5% | 0.03% | -66.7% |
| Q1 2015 | $14,083,000 | – | 1,177,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |